Thryv Therapeutics
0 followers
Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T waveQ and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated wit... Read more
Org chart
Paul F. Truex
Chairman & CEO
Paul F. Truex
Collapse
Debra Odink
President & Chief Development Officer
Philip Sager
Chief Medical Officer
Aidan McNeil
Associate General Counsel & VP, Administration
Eric Campeau
VP, Translational Research
Marc Vidal
Senior Director, Product & Process Development
Alexandre Brkovic
Senior Director, Program Management
Curtis Mcgrath
Associate Director, Finance
Daphne Doucet
Manager, Corporate Communications
